Head-to-head · WeighScore
MyDrHank vs Trimi
The verdict
Trimi takes it — 86.4/100 to 68.2/100.
Trimi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | MyDrHank | Trimi |
|---|---|---|
| WeighScore | 68.2/100 | 86.4/100 |
| Grade | C | B |
| Scorecard rank | #94 | #5 |
| Semaglutide | $249/mo oral, $259/mo injectable | $129/mo |
| Tirzepatide | $349/mo | $199/mo |
| Coverage | 44 states (KS, LA, MS, NM, ND, WV excluded) | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #94 · C
Strengths
- Prices are published openly on the product pages, before any intake quiz — most compounded competitors gate the number behind a questionnaire
- A real oral semaglutide tablet ($249/mo month-to-month) beside the weekly injection, so the needle is optional on the semaglutide line
- The GLP-1 pages state the price stays the same at every dose, so titrating up does not raise the monthly cost
- Six prescription lines on one account — weight loss, longevity, peptides and NAD+, sexual health, hair growth and strength — with free shipping included
- Clean against the FDA warning-letter database: no letter on file under the brand, the entity or the domain
Where it loses points
- Every price MyDrHank displays is the twelve-month prepay rung — its price component renders the cheapest term in the ladder, so the month-to-month rate ($259 semaglutide, $349 tirzepatide) appears on no page on the site
- Month-to-month, it is expensive: $259 semaglutide against a $179 median across the providers here that disclose one, and $349 tirzepatide against a $249 median
- One advertised price is purchasable at no tier — a footnote quotes "$200/mo for compounded tirzepatide" when the cheapest tirzepatide rung is $240, and the "$171/mo" beside it is the oral product's yearly rate, not injectable semaglutide's ($178)
- An FAQ describes a twelve-month prepay rate as a plan with "no contract"
- Compounded only and not FDA-approved — no brand Wegovy, Ozempic, Zepbound or Mounjaro lane at any price
- The operating entity is named — Dr. Hank, LLC, credited in the privacy policy and terms of use — but nobody clinical is: no medical director or prescriber appears anywhere, no lab or monitoring programme is published, and the compounding pharmacy is described only as "an FDA-registered U.S. pharmacy"
- The trust row reads "HIPAA-aware", not HIPAA-compliant — a hedge worth noticing on a site handling prescription intake
- No served-states list appears on the consumer site; the affiliate terms exclude Kansas, Louisiana, Mississippi, New Mexico, North Dakota and West Virginia
Graded #5 · B
Strengths
- Low flat pricing on both semaglutide and tirzepatide
- Both molecules on a single membership
- Free shipping to all 50 states
- Fast dispatch once the prescriber signs off
Where it loses points
- Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
- Injection only — no oral or sublingual route
- Dispensing pharmacy not publicly named
- Shorter public track record than the incumbents
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 506 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.